Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity was posted on December 10, 2008. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Blood Products and Immohematologic Services

Closed
IHS-SOL-0900057Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621991
New
Federal
Human Cadaver - Based Medical Training and Program Support Services for the 44th Medical Brigade stationed at Fort Bragg Army Base, North Carolina.
Solicitation # 0012468284
The Medical Acquisition Support Office – Alpha is seeking capable vendors to provide human cadaver-based medical training and program support for the 44th Medical Brigade. The scope of work includes the procurement and delivery of up to 20 ethically sourced, non-dissected perfused whole-body cadaver specimens annually, which must be serologically negative for HIV, Hepatitis B/C, and Syphilis. The contractor is responsible for providing refrigerated transportation to primary performance sites at Fort Bragg, NC; Fort Campbell, KY; Fort Stewart-Hunter Army Airfield, GA; and Fort Polk, LA. Additionally, the contractor must provide rental medical equipment and consumable Class VIII supplies, such as surgical packs, tourniquets, and simulated blood. The requirement includes providing highly qualified Subject Matter Experts (SMEs) to support up to 10 training events per fiscal year. These SMEs must be board-certified general surgeons with specific competencies in various trauma procedures, such as cricothyroidotomy and exploratory laparotomy, to serve as instructors and mentors. The anticipated contract structure consists of a base period followed by four one-year option periods. All personnel must comply with strict Installation Access Control System requirements, including Anti-Terrorism Level I and iWatch training, to gain access to military installations.
W40M MRC0 West

POSTED

2 days ago

DEADLINE

in 9 days
NAICS: 621991
New
Federal
6505--Human Blood and Blood Products
Solicitation # 36C25727Q0049
The Department of Veterans Affairs, Network Contracting Office 17, intends to award a single-award, firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the South Texas Blood and Tissue Center. This procurement is for the supply and delivery of human blood and blood products, as well as guidance in clinical pathology procedures, to support the Audie L. Murphy Veterans Health Care Center within the South Texas Veterans Health Care System in San Antonio, Texas. The government is pursuing this as a sole source procurement under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.103-1, asserting that only one responsible source can satisfy the agency's requirements. The contractor must maintain AABB and College of American Pathologists (CAP) accreditation and hold an unrevoked U.S. license from the FDA Bureau of Biologics. Key operational requirements include 24/7/365 availability and a tiered delivery system: STAT orders must be delivered within 60 minutes, ASAP orders within 2 hours, and routine orders within 24 hours. All products must be collected via closed systems under aseptic conditions, labeled according to the ABO Blood Group System and Rh type, and transported in compliance with FDA, AABB, and DOT regulations to ensure proper temperature maintenance. Acceptance of deliveries is based on STVHCS Blood Bank criteria, including physical appearance, contamination checks, and specific shelf-life minimums for red blood cells, plasma, and cryoprecipitate.
257-NETWORK Contract Office 17 (36C257)

POSTED

6 days ago

DEADLINE

in 15 days
NAICS: 621991
New
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute (NCI) has issued a Limited Competition Notice of Funding Opportunity (RFA-CA-28-004) to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain these national resources for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens. These resources facilitate translational cancer research, biomarker development, and validation by providing essential specimens from NCI-funded clinical trials. The NCI intends to fund approximately six awards for fiscal year 2027, with a total estimated funding of 19 million dollars and a maximum budget of 3 million dollars in direct costs per year for a requested project period of six years. Applications will be evaluated through the NIH peer-review system based on scientific and technical merit, significance, and the adequacy of the institutional environment. Key requirements for applicants include maintaining active registrations in SAM, eRA Commons, and Grants.gov, as well as providing specific documentation regarding the current scale of operations, accomplishments, and standard operating procedures. Awardees must adhere to NCI Best Practices for Biospecimen Resources, federal human subjects regulations under 45 CFR 46, and strict cybersecurity incident reporting protocols, including notification of incidents within 48 hours of discovery. The scope of work includes managing secure informatics systems, providing specimen collection kits, and ensuring the availability of annotated biospecimens for authorized investigators.
National Institutes Of Health

POSTED

6 days ago

DEADLINE

in 4 months
NAICS: 621991
New
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.
National Cancer Institute

POSTED

7 days ago

DEADLINE

in 4 months
NAICS: 621991
SLED
Mobile Health Unit OperationsThe contract titled Mobile Health Unit Operations seeks a subcontractor to manage the operation and maintenance of mobile units tasked with delivering vision, dental, and hearing services to underserved communities across the region. These mobile units will serve as critical access points for essential health care, ensuring that populations with limited transportation or geographic barriers receive timely and consistent medical attention. The work involves the full lifecycle management of the units, including routine maintenance, repairs, staffing coordination, logistics, and compliance with health and safety standards to guarantee reliable service delivery. The contract is categorized as a subcontract under NAICS code 621991 and is solicited by the Houston-Galveston Area Council through the Texas SmartBuy platform. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2027, providing over a year for prospective vendors to prepare proposals. The place of performance spans the region served by the council, though exact locations are not specified, indicating flexibility in service deployment based on community need. While details on set-aside status and point of contact are unavailable, the focus remains on operational excellence and equitable access to preventive and diagnostic health services in areas lacking permanent clinical infrastructure.
HOUSTON-GALVESTON AREA COUNCIL

POSTED

3 months ago

DEADLINE

in 9 months

General Info

Agency

N/A

NAICS

621991 - Blood and Organ Banks

Place of Performance

Claremore Indian Hospital, 101 S. Moore Avenue,, CLAREMORE, OK, 74017, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update
PhaseClosed
Posted

Combined Synopsis

Notice updated

Response deadline changed from Dec 19, 2008 to Dec 29, 2008. The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Yolanda C ReynaSupervisory Contract Specialist
Avis LonghornProcurement Tech

Full Description

Show more
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number is IHS-SOL-0900057 for Blood Products and Immunohematologic services. This solicitation is issued as a Request for Quotation (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-27. The NAIC code is 621991 and the small business size standard is $10M. Blood Product and Immunohematologic services Period of performance: Base Year January 1, 2009 through December 31, 2009; plus four option years. Evaluation will be based on products, technical service, pickup and delivery services and past performance Products is 40 percent; ability to supply blood products routinely and on an emergency basis and ability to supply leukocyte reduced red blood cells, fresh frozen plasma and platelets Technical service is 30 percent; ability to provide technical services for antibody identification, unit screening for particular antigens, antigen typing, comparability testing and consultation services during hospital normal working hours and off hours. Pickup delivery service is 20 percent; ability to provide regular pickup and delivery services for blood products; with STAT services as needed. Past Performance is 10 percent, ability to provide documentation of past performance of satisfactory service performed in a federal facility. Offeror shall provide past performance references with name, contact name, period of performance and telephone number. Offerors are to include a completed copy of the provision found at FAR 52.212-3, Offeror Representations and Certifications - Commercial Items with its offer. The clause found at FAR 52.212-4, Contract Terms and Conditions - Commercial Items applies to this acquisition. The clause found at FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items applies to this acquisition. FAR 52.212-1 Instructions to Offerors - Commercial applies to this acquisition. http://www.arnet.gov/far/ Offers are due December 19, 2008, 4:30 p.m. CDT at Division of Acquisition Management, 701 Market Drive, Oklahoma City, OK 73114.. Contact Yolanda Reyna at yolanda.reyna@ihs.gov for information regarding the solicitation or fax number 405/951-3771. PURPOSE: This is a non-personal services contract for the Claremore Indian Hospital for the time period beginning January 1, 2009 through December 31, 2009, with four pre-priced option years. Background. The Claremore Indian Health Service Hospital is located in Claremore, Oklahoma and serves the Indian population of most of northeastern Oklahoma. The hospital is a 50-bed JCAHO accredited facility which includes an Intensive Care Unit, Obstetrics Unit, Surgery and Same-day Surgery Units, and a General Medical Unit. In addition to the inpatient facilities, this hospital also serves an average of four hundred outpatients daily Monday through Friday in the Medical Clinic, Walk-in Clinic, OB-GYN Clinic, Diabetes Clinic, Surgery Clinic, Pediatrics Clinic, and several other specialty clinics. The Emergency Room is operational 24 hours per day, seven days per week. The Claremore IHS Hospital Laboratory is a College of American Pathologist and CLIA accredited laboratory. It is staffed 24 hours per day, seven days per week and must provide blood products and services for the patient population as prescribed by the Healthcare Provider. The Claremore Laboratory does not have sufficient staffing, equipment, or space to provide these particular services. There are no efforts being made that will duplicate this service. Upon award of a contract all open market purchases will be canceled. Independently, and not as an agent of the Government, the Contractor shall provide blood products and immunohematologic services. The Contractor shall provide the facilities, equipment, personnel, materials and supplies except as may be otherwise provided herein by the Government, Products to be provided: Leukocyte Reduced Red Blood Cells, Fresh Frozen Plasma, Platelets. Technical Services to be provided: The Contractor shall provide professional immunohematologic clinical laboratory testing to include: Antibody identification (including ABO/Rh, antibody screen, complete red cell antigen phenotype, comprehensive DAT and red cell panel), Unit screening for particular antigens, Antigen typing, Compatibility testing to be provided with a turn around time of 4 hours for routines and not to exceed 8 hours for nonroutine or unusual blood requirements. Reports for immunohematologic testing shall be provided by fax within 12 hours of receiving the sample unless (rare instances) the testing requires a longer time for completion. A typed report shall be provided to the facility in the next scheduled pick-up delivery visit or mailed within 24 hours of testing. Consultation Services shall be provided on an as needed basis to be determined by the Blood Bank medical technologist, a contact person to be made available 24 hours per day, seven days per week. Pick up/Delivery Services: The Contractor shall provide two scheduled pick ups and delivery services per week. The contractor shall provide any special transport containers or transport environment needed for preservation of blood products and specimens during the transport. Lost or Unsatisfactory Specimens: The Contractor shall provide a report of lost or unsatisfactory specimens for every lost, missing, damaged, or otherwise unsatisfactory specimen. The Contractor shall provide STAT pick up and delivery services with a response time of one hour. An Indefinite Delivery/Indefinite Quantity (IDIQ) contract will be awarded and task orders issued against the IDIQ contract. Offerors shall submit unit price for each product listed for the base plus option years. FAR part 17 will be applicable to the awarded contract.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS